三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
40周最佳矫正视力(BCVA)较基线改善(观测值)
40周最佳矫正视力(BCVA)较基线改善(观测值)
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:111KB
图片尺寸:1141*685
同报告图片
/
4
fCBXZWVrcyB8IElCSTMwMiA2LjRtZyBCQ1ZBIENoYW5nZSAobGV0dGVycykgfCBJQkkzMDIgOC4wbWcgQkNWQSBDaGFuZ2UgKGxldHRlcnMpIHwgQWZsaWJlcmNlcHQgMi4wbWcgQkNWQSBDaGFuZ2UgKGxldHRlcnMpIHwKfC0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS18CnwgMCAgICAgfCAwLjAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfCAwLjAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfCAwLjAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IDQgICAgIHwgNS4wICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgNS4wICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgNS4wICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKfCA4ICAgICB8IDcuMCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IDcuMCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IDcuMCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgMTIgICAgfCA5LjAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfCA5LjAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfCA5LjAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IDE2ICAgIHwgMTAuMCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgMTAuMCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgMTAuMCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKfCAyMCAgICB8IDEwLjUgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IDEwLjUgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IDEwLjUgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjQgICAgfCAxMS4wICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfCAxMS4wICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfCAxMS4wICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IDI4ICAgIHwgMTEuMCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgMTEuMCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgMTEuMCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKfCAzMiAgICB8IDExLjAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IDExLjAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IDExLjAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgMzYgICAgfCAxMS4wICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfCAxMS4wICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfCAxMS4wICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IDQwICAgIHwgMTEuMCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgMTEuMCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgMTEuMCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKCui1hOaWmeadpea6kO+8muWFrOWPuDIwMjTkuK3miqXmnZDmlpnvvIzmtZnllYbor4HliLjnoJTnqbbmiYA=
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
所属报告:
信达生物-港股公司深度报告:IO+ADC 全球创新领先减重等慢病开花-250427(30页).pdf
打包全文图表
相关数据
中国I期伏罗尼布有效提升52周BCVA字母数
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
收藏
行业数据
2026-07-03
原图定位
查看详情
LUCERNE中至第1年(第48周)BCVA较基线的变
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
收藏
行业数据
2025-07-21
原图定位
查看详情
RHINE中至第2年(第100周)BCVA较基线的变
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
收藏
行业数据
2025-07-21
原图定位
查看详情
YOSEMITE中至第2年(第100周)BCVA较基线的
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
收藏
行业数据
2025-07-21
原图定位
查看详情
RGX-314给药后最佳矫正视力水平(BCVA)和中
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
收藏
行业数据
2025-07-21
原图定位
查看详情
4D-150给药后最佳矫正视力水平(BCVA)和中
fCDlm77ooaggNDY6IDRELTE1MCDnu5noja/lkI7mnIDkvbPnn6vmraPop4blipvmsLTlubPvvIhCQ1ZB77yJ5ZKM5Lit5aSu5a2Q5Zy65Y6a5bqm77yIQ1NU77yJ5Y+Y5YyW5oOF5Ya1IHwKfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwKfCBCZXN0IENvcnJlY3RlZCBWaXN1YWwgQWN1aXR5IHwgQ2VudHJhbCBTdWJmaWVsZCBUaGlja25lc3MgfAp8IFdlZWsgNTI6ICsyLjMgfCBXZWVrIDUyOiAtMTEgfAp8IFdlZWsgNTI6ICsyLjIgfCBXZWVrIDUyOiAtMTMgfAp8IOi1hOaWmeadpea6kO+8mjREIG1vbGVjdWxhciB0aGVyYXBldXRpY3PlrpjnvZHvvIzljY7mupDor4HliLjnoJTnqbbmiYAgfA==
收藏
行业数据
2025-07-21
原图定位
查看详情
TENAYA中至第1年(第48周)BCVA较基线的变
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
收藏
行业数据
2025-07-21
原图定位
查看详情
相比基线平均BCVA变化(假性白内障患者)
fCAgTW9udGggfCAgSUxVVklFTihOPTY2KSB8ICBTaGFtKE49MzQpIHwKfC0tLXwtLS18LS0tfAp8IDAgfCA2LjEoMTMuNSkgfCAyLjkoMTYuNSkgfAp8IDYgfCA2LjEoMTMuNSkgfCAyLjkoMTYuNSkgfAp8IDEyIHwgNi4xKDEzLjUpIHwgMi45KDE2LjUpIHwKfCAxOCB8IDYuMSgxMy41KSB8IDIuOSgxNi41KSB8CnwgMjQgfCA2LjEoMTMuNSkgfCAyLjkoMTYuNSkgfAp8IDMwIHwgNC44KDE3LjgpIHwgMy41KDE2LjEpIHwKfCAzNiB8IDQuOCgxNy44KSB8IDMuNSgxNi4xKSB8CgrotYTmlpnmnaXmupDvvJpBbGltZXJh5YWs5Y+45a6Y572R77yM5aSp6aOO6K+B5Yi456CU56m25omA
收藏
行业数据
2025-06-23
原图定位
查看详情
相比基线平均BCVA变化(有症状的受试者)
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
收藏
行业数据
2025-06-23
原图定位
查看详情
高度近视患者后巩膜加固术后6个月BCVA变化[眼(%)]
收藏
行业数据
2021-03-08
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
IBI302(efdamrofusp alfa)是一种新型双靶点的特异性重组全人源融合蛋白,能同时结合 VEGF 和补体 C3b/C4b。其在抑制新生血管形成、降低血管渗透性和减少血管渗漏的同时,可抑制补体经典途径和旁路途经的激活,减少补体介导的炎症反应、黄斑萎缩和纤维化。2024 年 10月,信达生物在 2024 年美国眼科学会(AAO)年会上公布了 Efdamrofusp alfa 注射液在 nAMD 的临床 II 期数据。研究表明,高剂量 IBI302 展现出了积极的治疗效果,包括视力的提高,解剖结构的改善以及长间隔的给药潜力。其中 IBI302 6.4mg组维持Q12W给药间隔的受试者比例为 81%,8.0mg 组维持 Q12W 给药间隔的受试者比例为 88%。
行业数据
原图定位
当前图表所属:
信达生物-港股公司深度报告:IO+ADC 全球创新领先减重等慢病开花-250427(30页).pdf
IL-23靶点药物国内竞争格局(I期及以上)
玛仕度肽、司美格鲁肽及替尔泊肽不同剂量下减重数据对比(非头对头)
玛仕度肽共有7项III期注册研究进行中
CLDN18.2/CD3双靶点药物研发格局(申报临床及以上)
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》